TerumoMEX:4543N 91 FCF Margin % is 16.15% as of Mar. 2026, which is 103% above its 10-year median of 7.97. GuruFocus rates MEX:4543N with a GF Score™ of 91/100 and a GF Value™ of MXN373.91 (Significantly Undervalued). Among 815 Medical Devices & Instruments companies, Terumo ranks better than 76.44% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Terumo's Free Cash Flow for the
three
months ended in Mar. 2026 was MXN5,511 Mil. Terumo's Revenue for the
three
months ended in Mar. 2026 was MXN34,128 Mil. Therefore, Terumo's FCF Margin % for the quarter that ended in Mar. 2026 was 16.15%.
The historical rank and industry rank for Terumo's FCF Margin % or its related term are showing as below:
MEX:4543N'
s FCF Margin % Range Over the Past 10 Years
Min: 5.41 Med: 7.97 Max: 12.46
Current: 11.26
During the past 13 years, the highest FCF Margin % of Terumo was 12.46%. The lowest was 5.41%. And the median was 7.97%.
MEX:4543N's FCF Margin % is ranked better than 76.44% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.1
vs MEX:4543N: 11.26
Terumo FCF Margin % Related Terms
Terumo FCF Margin % Historical Data
* Premium members only.
The historical data trend for Terumo's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:4543N vs ISRG, BDX, MDLN: FCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Terumo's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Terumo FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Terumo's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Terumo's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Terumo (MEX:4543N) has a FCF Margin % of 16.15% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Terumo and its competitors. This is 103% above median its historical median of 7.97. Over the past decade, Terumo's FCF Margin % has ranged from 5.41 to 12.46. According to the industry distribution chart, Terumo ranks #192 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 23.6%.
Is Terumo's FCF Margin % too high?
Terumo's current FCF Margin % of 16.15% is 103% above median its 10-year median of 7.97. Over the past 10 years, this metric has ranged from a low of 5.41 to a high of 12.46. Based on the distribution chart, Terumo ranks #192 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Terumo has a GF Score™ of 91/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Terumo's FCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Terumo ranks #192 out of 815 companies for FCF Margin %. This places Terumo in the top 24% of its industry — outperforming the majority of peers. Historically, Terumo's own FCF Margin % has ranged from 5.41 to 12.46 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Terumo and its competitors. Terumo's current FCF Margin % is 16.15%, which is 103% above median its own 10-year median of 7.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Terumo stock overvalued right now?
Based on GuruFocus' analysis, Terumo (MEX:4543N) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN373.91, compared to a current price of MXN261.28 — trading 30.1% below its estimated fair value. The current FCF Margin % is 16.15%, which is 103% above median its 10-year median of 7.97. Terumo's overall GF Score™ is 91/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Terumo (MEX:4543N), the current FCF Margin % is 16.15% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Terumo (MEX:4543N) Overvalued in 2026?
Based on GuruFocus' analysis, Terumo stock appears to be undervalued.
The current stock price of MXN261.28 is trading 30.1% below its estimated GF Value™ of MXN373.91.
GuruFocus considers Terumo to be Significantly Undervalued.
Key valuation signals for MEX:4543N:
FCF Margin %: 16.15% (103% above median its 10-year median of 7.97)
GF Value™: MXN373.91 vs. price of MXN261.28 (30.1% below fair value)
No single metric tells the full story. See the MEX:4543N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Started as a clinical thermometer producer in Japan in 1921, Terumo is a comprehensive medical device player with a diversified global revenue. Its product portfolio includes prefilled syringes, insulin patch pumps, neurovascular or cardiac vascular interventional devices, and blood processing systems. As of 2025, the cardiac and vascular business is the largest segment, contributing over 60% of its total revenue. Geographically, North America is the largest region, with 38% of Terumo's revenue.
91GF Score
Get the complete analysis for MEX:4543N
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:4543N has been successfully added to your 
